AD Pharma

Global Drugs for Chronic Obstructive Pulmonary Disorder Sales Market 2017 (Short-Acting Bronchodilators, Corticosteroids, Methylxanthines, Long-Acting Bronchodilators and Phosphodiesterase-4 Inhibitors) : Global QYResearch

Press Release   •   Feb 07, 2017 09:21 EET

This report studies sales (consumption) of Global Drugs for Chronic Obstructive Pulmonary Disorder Market 2017, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

AstraZeneca
Boehringer Ingelheim
GSK
Novartis
Teva Pharmaceuticals
Ache Laboratorios Farmaceuticos
Almirall
Aquinox Pharmaceuticals
Ario Pharma
Asmacure
Astellas Pharma
BioMarck Pharmaceuticals
Others

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Drugs for Chronic Obstructive Pulmonary Disorder in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India

Request more information at http://globalqyresearch.com/download-sample/157293 

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Short-Acting Bronchodilators
Corticosteroids
Methylxanthines
Long-Acting Bronchodilators
Phosphodiesterase-4 Inhibitors

Split by applications, this report focuses on sales, market share and growth rate of Drugs for Chronic Obstructive Pulmonary Disorder in each application, can be divided into
GOLD 1: FEV1 ≥ 80%
GOLD 2: 50% ≤ FEV1 < 80%
GOLD 3: 30% ≤ FEV1 < 50%
GOLD 4: FEV1 < 30%

View full report at http://globalqyresearch.com/global-drugs-for-chronic-obstructive-pulmonary-disorder-sales-market-report-2017

Table of Contents

Global Drugs for Chronic Obstructive Pulmonary Disorder Sales Market Report 2017
1 Drugs for Chronic Obstructive Pulmonary Disorder Overview
1.1 Product Overview and Scope of Drugs for Chronic Obstructive Pulmonary Disorder
1.2 Classification of Drugs for Chronic Obstructive Pulmonary Disorder
1.2.1 Short-Acting Bronchodilators
1.2.2 Corticosteroids
1.2.3 Methylxanthines
1.2.4 Long-Acting Bronchodilators
1.2.5 Phosphodiesterase-4 Inhibitors
1.3 Application of Drugs for Chronic Obstructive Pulmonary Disorder
1.3.1 GOLD 1: FEV1 ≥ 80%
1.3.2 GOLD 2: 50% ≤ FEV1 < 80%
1.3.3 GOLD 3: 30% ≤ FEV1 < 50%
1.3.4 GOLD 4: FEV1 < 30%
1.4 Drugs for Chronic Obstructive Pulmonary Disorder Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Drugs for Chronic Obstructive Pulmonary Disorder (2012-2022)
1.5.1 Global Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2022)
1.5.2 Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)

2 Global Drugs for Chronic Obstructive Pulmonary Disorder Competition by Manufacturers, Type and Application
2.1 Global Drugs for Chronic Obstructive Pulmonary Disorder Market Competition by Manufacturers
2.1.1 Global Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Share by Manufacturers (2012-2017)
2.2 Global Drugs for Chronic Obstructive Pulmonary Disorder (Volume and Value) by Type
2.2.1 Global Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type (2012-2017)
2.2.2 Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Market Share by Type (2012-2017)
2.3 Global Drugs for Chronic Obstructive Pulmonary Disorder (Volume and Value) by Regions
2.3.1 Global Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Regions (2012-2017)
2.3.2 Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Market Share by Regions (2012-2017)
2.4 Global Drugs for Chronic Obstructive Pulmonary Disorder (Volume) by Application

3 United States Drugs for Chronic Obstructive Pulmonary Disorder (Volume, Value and Sales Price)
3.1 United States Drugs for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
3.1.1 United States Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
3.1.2 United States Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
3.1.3 United States Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
3.2 United States Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
3.3 United States Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
3.4 United States Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application

4 China Drugs for Chronic Obstructive Pulmonary Disorder (Volume, Value and Sales Price)
4.1 China Drugs for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
4.1.1 China Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
4.1.2 China Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
4.1.3 China Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
4.2 China Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
4.3 China Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
4.4 China Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application

5 Europe Drugs for Chronic Obstructive Pulmonary Disorder (Volume, Value and Sales Price)
5.1 Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
5.1.1 Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
5.1.2 Europe Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
5.1.3 Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
5.2 Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
5.3 Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
5.4 Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application

6 Japan Drugs for Chronic Obstructive Pulmonary Disorder (Volume, Value and Sales Price)
6.1 Japan Drugs for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
6.1.1 Japan Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
6.1.2 Japan Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
6.1.3 Japan Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
6.2 Japan Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
6.3 Japan Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
6.4 Japan Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application
7 Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder (Volume, Value and Sales Price)
7.1 Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
7.1.1 Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
7.2 Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
7.3 Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
7.4 Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application
8 India Drugs for Chronic Obstructive Pulmonary Disorder (Volume, Value and Sales Price)
8.1 India Drugs for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
8.1.1 India Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
8.1.2 India Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
8.1.3 India Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
8.2 India Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
8.3 India Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
8.4 India Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application

9 Global Drugs for Chronic Obstructive Pulmonary Disorder Manufacturers Analysis
9.1 AstraZeneca
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
9.1.2.1 Short-Acting Bronchodilators
9.1.2.2 Corticosteroids
9.1.3 AstraZeneca Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Boehringer Ingelheim
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
9.2.2.1 Short-Acting Bronchodilators
9.2.2.2 Corticosteroids
9.2.3 Boehringer Ingelheim Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 GSK
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
9.3.2.1 Short-Acting Bronchodilators
9.3.2.2 Corticosteroids
9.3.3 GSK Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Novartis
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
9.4.2.1 Short-Acting Bronchodilators
9.4.2.2 Corticosteroids
9.4.3 Novartis Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Teva Pharmaceuticals
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
9.5.2.1 Short-Acting Bronchodilators
9.5.2.2 Corticosteroids
9.5.3 Teva Pharmaceuticals Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Ache Laboratorios Farmaceuticos
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
9.6.2.1 Short-Acting Bronchodilators
9.6.2.2 Corticosteroids
9.6.3 Ache Laboratorios Farmaceuticos Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Almirall
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
9.7.2.1 Short-Acting Bronchodilators
9.7.2.2 Corticosteroids
9.7.3 Almirall Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Aquinox Pharmaceuticals
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
9.8.2.1 Short-Acting Bronchodilators
9.8.2.2 Corticosteroids
9.8.3 Aquinox Pharmaceuticals Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Ario Pharma
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
9.9.2.1 Short-Acting Bronchodilators
9.9.2.2 Corticosteroids
9.9.3 Ario Pharma Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Asmacure
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
9.10.2.1 Short-Acting Bronchodilators
9.10.2.2 Corticosteroids
9.10.3 Asmacure Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Astellas Pharma
9.12 BioMarck Pharmaceuticals
9.13 Others

10 Drugs for Chronic Obstructive Pulmonary Disorder Maufacturing Cost Analysis
10.1 Drugs for Chronic Obstructive Pulmonary Disorder Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Drugs for Chronic Obstructive Pulmonary Disorder
10.3 Manufacturing Process Analysis of Drugs for Chronic Obstructive Pulmonary Disorder

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Drugs for Chronic Obstructive Pulmonary Disorder Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Drugs for Chronic Obstructive Pulmonary Disorder Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Drugs for Chronic Obstructive Pulmonary Disorder Market Forecast (2017-2022)
14.1 Global Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Drugs for Chronic Obstructive Pulmonary Disorder Price and Trend Forecast (2017-2022)
14.2 Global Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Drugs for Chronic Obstructive Pulmonary Disorder Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

To Purchase this premium Report With Complete TOC at http://globalqyresearch.com/checkout-form/0/157293

About Us:

Global QYResearch (http://globalqyresearch.com/ ) is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact Us:

Unit1, 26 Cleveland Road, South Woodford, London, E182AN, United Kingdom

Contact: +44 20 32392407

Email: sales@globalqyresearch.com

Follow us:https://www.linkedin.com/company/global-qy-research

Twitter: https://twitter.com/gqyresearch